Progesterone receptor modulators

2010
OA: closed
⚙ AI-generated summary by qwen3.7-flash, 2026-09-05 ⓘ

This patent discloses progesterone receptor modulating steroids with dual agonistic and antagonistic activities, specifically identifying their utility in treating endometriosis, gynecological disorders, hormone replacement therapy, and contraception.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Disclosed are progesterone receptor modulating steroids of formula (I) which have both agonistic and antagonistic modulating activities towards the progesterone receptor, processes for their preparation, and their use in therapy, wherein the variables shown in formula (I) are as defined in the specification. These compounds of formula (I) are suitable for the treatment of endometriosis, for hormone replacement therapy or for the treatment of a gynaecological disorder, and as a contraceptive.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-11T09:27:45.537177+00:00